首页 > 产品目录 > 信号通路 > PI3K/Akt/mTOR > mTOR > (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-二羟基-3-((R)-1-((1S,3R,4R)-4-(2-羟基乙氧基)-3-甲氧基环己基)丙-2-基)-10,21-二甲氧基-6,8,12,14,20,26-六甲基-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-十六氢-3H-23,27-环氧吡啶并[21-c][1]氧杂]4]氮杂环;依维莫司

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-二羟基-3-((R)-1-((1S,3R,4R)-4-(2-羟基乙氧基)-3-甲氧基环己基)丙-2-基)-10,21-二甲氧基-6,8,12,14,20,26-六甲基-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-十六氢-3H-23,27-环氧吡啶并[21-c][1]氧杂]4]氮杂环;依维莫司

ChemLeader 98+%

Everolimus | RAD-001

产品编号:CL2331 CAS No.:159351-69-6 MDLNo:MFCD00929329 分子式:C53H83NO14 分子量:958.22
规格 库存 目录价 会员专享价 数量
10 mg In-stock ¥328.00 登录后可见
- +
25 mg In-stock ¥568.00 登录后可见
- +

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

  • 基本信息
  • 相关文档
  • 产品详情
  • 相关文献
基本信息
英文名称 Everolimus | RAD-001
中文名称(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-二羟基-3-((R)-1-((1S,3R,4R)-4-(2-羟基乙氧基)-3-甲氧基环己基)丙-2-基)-10,21-二甲氧基-6,8,12,14,20,26-六甲基-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-十六氢-3H-23,27-环氧吡啶并[21-c][1]氧杂]4]氮杂环;依维莫司
CAS号159351-69-6
分子式C53H83NO14
分子量958.22
MDLMFCD00929329
外观White to off-white powder
储存条件Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
产品详情

 Everolimus, also known as RAD001, is a derivative of the natural macrocyclic lactone sirolimus with immunosuppressant and anti-angiogenic properties. In cells, everolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian Target of Rapamycin (mTOR), a key regulatory kinase. Inhibition of mTOR activation results in the inhibition of T lymphocyte activation and proliferation associated with antigen and cytokine (IL-2, IL-4, and IL-15) stimulation and the inhibition of antibody production.


相关产品
抱歉,暂时没有相关产品
在线客服
小德
021-58180488
小立
021-58180488
在线服务时间: 工作日 9:00-18:00